Measuring and Interpreting Holo-Transcobalamin (Holo-Transcobalamin II)

Author:
Open Access
Publisher website
Google Scholar
Abstract
At one time, diagnosing cobalamin deficiency was fairly simple, usually involving a patient with clinical problems, and was usually settled by determining whether the serum cobalamin concentration was low or not. As reviewed elsewhere ( 1), things began to change after sensitive metabolic tests were introduced and as attention extended to the cobalamin status of asymptomatic persons. Metabolic studies confirmed that most low cobalamin concentrations in asymptomatic patients and seemingly healthy persons represented subclinical cobalamin insufficiency, but ∼30–40% of these cobalamin concentrations did not represent insufficiency and thus could be considered “falsely low”. The diagnostic reliability of serum cobalamin was further challenged by metabolic demonstrations of “falsely normal” cobalamin concentrations; these too occurred most often, but not exclusively, in asymptomatic persons.

This publication has 13 references indexed in Scilit: